Henry Schein (NASDAQ:HSIC) is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.
In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes. This includes practice management software, e-commerce platforms, digital imaging systems, and advanced sterilization and infection control solutions. The company also offers financial services, consulting, and supply chain management programs designed to help healthcare practices optimize inventory, reduce operating costs and comply with regulatory requirements.
Founded in 1932 by Henry Schein in Queens, New York, the company has grown from a small health products supplier into a Fortune 500 organization headquartered in Melville, New York. Over the decades, Henry Schein has expanded through strategic acquisitions and organic growth, establishing a presence in more than 30 countries and serving over one million customers worldwide. Its global logistics network and local market expertise enable rapid delivery of products and responsive support for healthcare professionals across North America, Europe, Asia Pacific, Latin America and Africa.
Under the leadership of Chairman and Chief Executive Officer Stanley M. Bergman, who joined the company in the late 1980s, Henry Schein has pursued a strategy centered on customer service excellence, innovation and partnerships. The company collaborates with manufacturers, technology developers and professional associations to introduce new solutions and best practices to the marketplace. With a commitment to sustainability and community engagement, Henry Schein continues to invest in research, education and outreach programs that support the health and well-being of practitioners and patients around the world.
